GO:0039694 viral RNA genome replication

Viral RNA genome replication (GO:0039694) is the biological process by which RNA viruses synthesize new copies of their RNA genomes within infected host cells. This process is central to the life cycle of many medically important viruses, including flaviviruses, coronaviruses, picornaviruses, and influenza A virus. Unlike cellular DNA replication, viral RNA genome replication often occurs in specialized membrane-associated replication organelles and relies on a combination of viral replicase proteins and host factors. Understanding the molecular details of this process is essential for identifying antiviral targets and for interpreting how mutations in viral or host genes affect viral fitness. Research on viral RNA genome replication has revealed that different RNA virus families use distinct strategies. Positive-strand RNA viruses, such as flaviviruses and coronaviruses, translate their genomes immediately upon entry and then use the resulting viral proteins to build replication complexes that copy the RNA genome through a negative-strand intermediate. Picornaviruses also use positive-strand RNA genomes but employ non-template functions of viral RNA, including structured RNA elements, to regulate replication and packaging. In contrast, negative-strand RNA viruses like influenza A virus package their RNA genome into ribonucleoprotein complexes and require host factors such as ANP32 proteins to support efficient replication. These differences highlight the need for family-specific research approaches. The importance of GO:0039694 extends beyond basic virology. Because viral RNA genome replication is essential for viral propagation, it is a prime target for antiviral therapeutics and for understanding viral pathogenesis. Moreover, host factors that support or restrict viral RNA genome replication can be studied using CRISPR knockout, point-mutation, knock-in, and overexpression models, enabling systematic dissection of virus-host interactions. This article provides a research-grade overview of the mechanisms, key genes, disease links, and experimental methods associated with GO:0039694.

GO:0039694 viral RNA genome replication is defined as the replication of a viral RNA genome. In practical terms, it encompasses all molecular events that lead to the synthesis of new viral RNA genomes from an existing viral RNA template, including the assembly of viral replicase complexes, RNA synthesis, and the coordination of replication with other steps of the viral life cycle.

Viral RNA genome replication is a central step in the life cycle of RNA viruses and a major determinant of viral amplification and pathogenesis. Because this process is essential for producing progeny virions, it represents a high-value target for antiviral intervention and a focal point for understanding how viruses co-opt host machinery. Research on GO:0039694 also informs vaccine design, epidemiological modeling, and the development of broad-spectrum antivirals against emerging RNA viruses.

The following genes and proteins are central to viral RNA genome replication across different RNA virus families, based on published literature.

Viral RNA genome replication is regulated at multiple levels, including viral RNA structures, viral proteins, and host factors. For influenza A virus, host ANP32 proteins interact with the viral nucleoprotein to promote replication, and this interaction is a point of regulation. Flaviviruses and coronaviruses regulate replication through membrane remodeling and the formation of replication organelles, which are influenced by host lipid metabolism and signaling. Picornaviruses use non-template functions of viral RNA, including cis-acting replication elements, to coordinate replication with translation and encapsidation. Additionally, viral proteins such as KSHV ORF57 regulate RNA splicing and processing, which can indirectly affect replication. These regulatory layers provide opportunities for therapeutic intervention and for studying virus-host interactions.

Flaviviruses such as dengue, Zika, and West Nile viruses cause significant human disease, and their replication depends on membrane-associated replication organelles. Understanding viral RNA genome replication is essential for developing antivirals and vaccines against these pathogens.

Coronaviruses, including SARS-CoV-2, use a complex replication strategy with proofreading and discontinuous transcription, making them a paradox among positive-strand RNA viruses. Targeting viral RNA genome replication is a major strategy for antiviral development against coronaviruses.

Influenza A virus causes seasonal epidemics and pandemics, and its replication relies on host ANP32 proteins. Studying these host dependencies can inform the development of host-directed antivirals and help predict emerging viral threats.

Picornaviruses cause a range of diseases, from the common cold to poliomyelitis, and their replication is regulated by non-template functions of viral RNA. Understanding these mechanisms supports the development of antivirals and vaccines.

RNA sequencing and quantitative RT-PCR are used to measure viral RNA genome replication by quantifying viral RNA levels over time. These methods can distinguish between positive-strand and negative-strand RNA intermediates and assess the impact of host gene knockouts.

Genome-wide CRISPR knockout and activation screens identify host factors that promote or restrict viral RNA genome replication. These screens are particularly powerful for discovering host dependency factors such as ANP32 proteins for influenza A virus.

Fluorescence microscopy and electron microscopy reveal the formation of replication organelles and the localization of viral replicase proteins. Tagged knock-in cell lines enable live-cell imaging of replication complex dynamics.

In vitro replication assays using purified viral polymerases and RNA templates measure catalytic activity and the effects of mutations. These assays are complemented by structural studies of replicase complexes.

Researchers studying viral RNA genome replication-related genes often need to determine whether a candidate gene is causally involved in viral replication or is merely correlated with infection. CRISPR-based models provide a rigorous way to test causality by manipulating host or viral genes and measuring the effects on viral RNA synthesis.

GO:0039694 viral RNA genome replication is a fundamental biological process that underpins the life cycle of diverse RNA viruses. Research across flaviviruses, coronaviruses, picornaviruses, and influenza A virus has revealed both shared principles and family-specific mechanisms, from membrane-associated replication organelles to host factor dependencies such as ANP32 proteins. Continued investigation using CRISPR-based models and functional genomics will be essential for identifying new antiviral targets and understanding viral pathogenesis.